Human Common Tissue MicroArray (Cancer)

Images

 
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 01. Endometrium Adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 02. Endometrium Adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 03. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 04. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 05. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 06. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 07. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 08. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 09. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 10. Endometrium adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 11. Gallbladder metastatic adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 12. Gallbladder adenocarcinoma, moderately diffrentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 13. Gallbladder, adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 14. Gallbladder adenosquamous carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 15. Gallbladder adenocarcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 16. Gallbladder, adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 17. Galbladder, adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 18. Gallbladder adenocarcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 19. Gallbladder adenocarcinoma well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 20. Gallbladder adenocarcinoma well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 21. Larynx Squamous cell carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 22. Larynx Squamous cell carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 23. Larynx adenoid cystic carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - Larynx squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 25. Larynx squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 26. Larynx squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 27. Larynx squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 28. Epiglottis squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 29. Oral cavity squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 30. Larynx squamous cell carcinoma, Well differentiated
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 31. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 32. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 33. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 34. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 35. Uterine cervix squamos cell
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 36. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 37. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 38. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 39. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 40. Uterine cervix squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 41. Neck malignant lymphoma, B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 42. Bone, femur malignant lymphoma, probably B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 43. Jejunum malignant lymphoma, B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 44. Cecum malignant lymphoma, B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 45. Stomach malignant lymphoma, probably B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 46. Retroperitoneum malignant lymphoma, probably B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 47. Stomach, malignant lymphoma, B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 48. Testis, malignant lymphoma, probably B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 49. Stomach, malignant lymphoma, B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 50. Duodenum malignant lymphoma, probably B cell origin
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 51.Skin, sole malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 52.Anus malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 53.Skin, toe malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 54. Skin, scalp malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 55.Skin, hip malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 56.Skin, abdomen malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 57.Skin, buttock malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 59. Maxillary sinus malignant melanoma
Hematoxylin & Eosin Stain: Human Common Tissue MicroArray (Cancer) [NBP2-30264] - 58.Skin, axilla malignant melanoma

Product Details

Summary
Reactivity HuSpecies Glossary
Applications IHC-P

Order Details

Human Common Tissue MicroArray (Cancer) Summary

Description
Microarray Panel:
Common cancers (3)
No. of samples 59
No. of patients 59
Core diameter 2.0 mm
Format:Formalin Fixed
Section thickness 4 micrometer
Core#
No.
Age Sex Organ Diagnosis pTNM Stage MCN4# Tissue
type
Image
1 62 F Endometrium adenocarcinoma T3cN0M0 IIIC . . 6
2 52 F Endometrium adenocarcinoma, endometrioid type T1bN0M0 I B D** . 6
3 57 F Endometrium adenocarcinoma, endometrioid type T1bN0M0 I B D** . 6
4 35 F Endometrium adenocarcinoma, endometrioid type T1b1N0M0 I B1 . . 6
5 38 F Endometrium adenocarcinoma T1aN0M0 I A . 105 6
6 53 F Endometrium adenocarcinoma, endometrioid type T2bN0M0 IIB . 106 6
7 41 F Endometrium adenocarcinoma, endometrioid type T3aN0M0 IIIA . 107 6
8 49 F Endometrium adenocarcinoma, endometrioid type T1aN0M0 I A D** . 6
9 53 F Endometrium adenocarcinoma, endometrioid type T2N0M0 II D** 109 6
10 52 F Endometrium adenocarcinoma, endometrioid type T1bN0M0 I B . 110 6
11 68 F Gallbladder metastatic adenocarcinoma from stomach . IV . . 6
12 67 F Gallbladder adenocarcinoma, moderately differentiated T4N0M0 III . 112 6
13 52 F Gallbladder adenocarcinoma, poorly differentiated T3N0M0 IIA . 113 6
14 54 F Gallbladder adenosquamous carcinoma T3N0M1 IV . 114 6
15 64 F Gallbladder adenocarcinoma, moderately differentiated T3N1M0 IIB . . 6
16 82 F Gallbladder adenocarcinoma, well differentiated T4N0M1 IV . . 6
17 50 M Gallbladder adenocarcinoma, well differentiated T2N1M0 IIB . . 6
18 52 M Gallbladder adenocarcinoma, moderately differentiated T3N0M0 IIA . . 6
19 64 M Gallbladder adenocarcinoma, well differentiated T2N0M0 I B . . 6
20 54 F Gallbladder adenocarcinoma, well differentiated T2N0M0 I B . . 6
21 51 M Larynx squamous cell carcinoma, well differentiated T4aN1M0 IVA . . 6
22 52 M Larynx squamous cell carcinoma, poorly differentiated T4aN1M0 IVA . . 6
23 68 M Larynx adenoid cystic carcinoma, largely solid type T4aN2bM0 IVA . 123 6
24 71 M Larynx squamous cell carcinoma, moderately differentiated T3N2bM0 IVA . . 6
25 50 M Larynx squamous cell carcinoma T4aN0M0 IVA . 125 6
26 61 F Larynx squamous cell carcinoma, moderately differentiated T3N2bM0 IVA . 126 6
27 69 M Larynx squamous cell carcinoma, well differentiated T3N0M0 III . 127 6
28 60 M Epiglottis squamous cell carcinoma, well differentiated T4aN1M0 IVA . 128 6
29 71 M Oral cavity squamous cell carcinoma, well differentiated T4bNXM0 IVB . 129 6
30 56 M Larynx squamous cell carcinoma, well differentiated T3N0M0 III . 130 6
31 64 F Uterine cervix squamous cell carcinoma T1b1N0M0 I B1 I B* . 6
32 59 F Uterine cervix squamous cell carcinoma T2bN1M0 III B IIA* 132 6
33 56 F Uterine cervix adenosquamous cell carcinoma T2aN0M0 IIA IIB* 133 6
34 50 F Uterine cervix squamous cell carcinoma T1b1N1M0 IIIB IIA* . 6
35 51 F Uterine cervix squamous cell carcinoma T3bN1M0 IIIB IIA* 135 6
36 32 F Uterine cervix squamous cell carcinoma T1bN1M0 IIIB IIB* . 6
37 42 F Uterine cervix squamous cell carcinoma T1bN1M0 IIIB IIA* . 6
38 63 F Uterine cervix squamous cell carcinoma T2bN1M0 IIIB IIB* . 6
39 42 F Uterine cervix squamous cell carcinoma T1bN0M0 I B II B* . 6
40 71 F Uterine cervix squamous cell carcinoma T2bN1M0 IIIB IIB* 140 6
41 26 M Neck malignant lymphoma, B cell origin . I . . 6
42 53 M Bone, femur malignant lymphoma, probably B cell origin . IV . . 6
43 83 M Jejunum malignant lymphoma, B cell origin . IV . . 6
44 43 M Cecum malignant lymphoma, B cell origin . IE . 144 6
45 69 M Stomach malignant lymphoma, probably B cell origin . IE . 145 6
46 63 M Retroperitoneum malignant lymphoma, probably B cell origin . I . . 6
47 49 M Stomach malignant lymphoma, B cell origin . IIE . . 6
48 51 M Testis malignant lymphoma, probably B cell origin . IE . . 6
49 60 F Stomach malignant lymphoma, B cell origin . IE . 149 6
50 69 M Duodenum malignant lymphoma, probably B cell origin . IE . . 6
51 66 M Skin, sole malignant melanoma T4aNXMX IIB . . 6
52 44 F Anus malignant melanoma . . . 152 6
53 20 M Skin, toe malignant melanoma T3aN2bM0 IIIB . . 6
54 22 F Skin, scalp malignant melanoma T4bNXM0 IIC . 154 6
55 53 M Skin, hip malignant melanoma T4aN2bM0 IIIB . . 6
56 73 F Skin, abdomen malignant melanoma T4aNXM1 IV . . 6
57 33 F Skin, buttock malignant melanoma TXNXM1 IV . 156 6
58 60 M Skin, axilla malignant melanoma T4bNXM1 IV . . 6
59 74. F Maxillary sinus malignant melanoma . . . . 6
60 . . Carbon . . . . . .


Applications/Dilutions

Publications
Read Publication using NBP2-30264.

Reactivity Notes

Human

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.

Details for Common

Type
Tissue
Tissue Condition
Cancer

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Tissue Micro Arrays are guaranteed for 1 year from date of receipt.

Publications for Common Tissue Micro Array (NBP2-30264)(1)

We have publications tested in 1 application: IHC-P.


Filter By Application
IHC-P
(1)
All Applications
Filter By Species
All Species

Reviews for Common Tissue Micro Array (NBP2-30264) (0)

There are no reviews for Common Tissue Micro Array (NBP2-30264). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Common Tissue Micro Array (NBP2-30264) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Common Products

Common NBP2-30264

Blogs on Common

There are no specific blogs for Common, but you can read our latest blog posts.

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Common Tissue MicroArray (Cancer) and receive a gift card or discount.